News overview

Oncode Icons Square groups
News
23 March 2021
Recent developments in single-cell genomics/epigenomics: highlights from this year’s first Masterclass
Advances in single-cell technologies are providing unprecedented opportunities to analyse the complexities of biological systems at exceptional resolutions. They provide means to gain a better understanding of diverse processes such as tumorigenesis, gene expression dynamics and tumour heterogeneity. In a masterclass organised via Zoom at the beginning of this year, Oncode Investigator Jop Kind and 7 other speakers, familiarized attendees with the field of single-cell genomics/epigenomics and its applications, including a virtual tour of the new single cell epigenomics facility.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>

MRT organoid IF
News
10 March 2021
Oncode Investigator Jarno Drost co-leads research that unravels the origin of a form of childhood cancer
Malignant rhabdoid tumor (MRT) is a rare type of childhood cancer. Its origins have been unknown until now. A recently published paper in Nature Communications, co-led by Oncode Investigator Jarno Drost in collaboration with researchers at Wellcome Sanger Institute unravels its origins. Beyond that, the study also identifies two drugs to fight it.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>

Louis Vermeulen
News
9 March 2021
Oncode Investigator Louis Vermeulen wins the prestigious Ammodo Science Award 2021
Oncode Investigator Louis Vermeulen (Amsterdam UMC) studies how derailments in the genetic material of stem cells can cause colon cancer, and focuses specifically on the earliest development of tumors. He combines biochemistry and genetics with mathematical and physical models to map the dynamics of stem cells. Because he is not afraid to venture outside the beaten path, his innovative approach has made a major contribution to fundamental concepts within molecular oncology. This is why he is amongst the eight outstanding mid-career scientists working in the Netherlands awarded this year’s Ammodo Science Award.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>

Oncode New Icons Square V2 support programmes2 copy 14
News
23 February 2021
License signed: Oncode successfully mediates agreement for innovative algorithm RAINFOREST
Oncode’s valorization team at work: we are happy to announce that SkylineDx has signed a license agreement with Oncode Institute and Utrecht Holdings on a shared patent covering the innovative algorithm RAINFOREST.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>

Rene en Deborah site
Story
4 February 2021
‘De vleugels van de wetenschap' - een verhaal over fundamenteel onderzoek met levens veranderende impact
- Dutch translation of the English article - Wat hebben de Nederlandse onderzoeker en Oncode Investigator Rene Bernards (NKI) en de Britse columniste en podcaster Deborah James met elkaar gemeen? Ze zijn beiden op een missie om kanker te bestrijden. Bernards ultieme doel is om zijn onderzoeksresultaten naar de kliniek te vertalen en daarmee impact te hebben op het leven van mensen. James veranderde de diagnose stadium 4 darmkanker in een missie, niet alleen om de ziekte te bestrijden, maar ook om het gesprek erover te veranderen. De twee ontmoetten elkaar in 2018: toen James geen behandelingsopties meer had, was het Bernards innovatieve therapie die haar te hulp schoot.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>

Rene en Deborah site
Story
4 February 2021
‘The Wings of Science’ – a story of basic research with real life impact
What do Dutch researcher and Oncode Investigator Rene Bernards (NKI) and British columnist and podcaster Deborah James have in common? They are both on a mission to fight cancer. Bernards’ ultimate goal is to bring his research findings to the clinic and by that to impact people’s lives. James turned her own stage 4 bowel cancer diagnosis into a mission not only to fight the illness but also to change the conversation around it. The two met in 2018: as James was running out of treatment options, it was Bernards’ innovative therapy that came to her rescue.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>

Screenshot 2021 01 28 at 09 03 46
News
28 January 2021
Minister De Jonge visits COVID-19 test robot co-invented by Oncode Investigators Tanenbaum and De Laat
Last Wednesday, January 27th, Dutch Minister of health Hugo de Jonge visited the medical microbiology laboratories at PAMM to witness the newly installed STRIP-1 test robot which was installed end of the year. This test robot is capable of processing 20.000 COVID-19 qPCR-tests per 24 hours, making it unique in the world.
PeterThijssen
Schumacher Ton 01
News
26 January 2021
Oncode Investigator Ton Schumacher wins the prestigious Jeantet-Collen Prize for Translational Medicine
This award comes in recognition of his work developing technologies to study the role of the immune system in cancer progression, and for the improvement of cancer diagnosis and treatment. He will share the prize with french scientist Jerome Galon from the Institut National de la Santé et de la Recherche Médicale (INSERM) in Paris.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>

NH20201125 016
News
16 December 2020
Biotech Wednesday – Spotlight on Cancer Treatments for the 21st Century
The second edition of Biotech Wednesday, an event organized by Oncode Institute in collaboration with HollandBio, switched locations, from Pakhuis de Zwijger to the online. What seemed at first a limitation turned out to be an opportunity. With a line-up of top speakers from both research and industry, and participants joining the event from 14 countries spread on three continents, this year’s digital edition of Biotech Wednesday was a success.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>

Quarterly Dec2020
News
4 December 2020
The December edition of Oncode’s digital magazine is here
Welcome to the last 2020 issue of Oncode’s digital magazine. As this unusual year comes to an end, December is the month to look back and forward.
Vesnade Jong

<span>Vesna</span><span>de Jong</span>

Vesna is a Digital Content Manager at Lygature, and is responsible for all things digital at Oncode. Originally from Slovenia, where she finished her MA in English language and literature, life led her to the Netherlands. Vesna has more than 10 years of experience in translation and localization, and has gained extensive experience of digital communications while working for one of the biggest online travel agencies.
Thumbnailt5Gr2Nz3
News
27 November 2020
A brand new video series about the Clinical Proof of Concept landscape
As part of the Clinical Proof Concept programme, the Oncode Exploratory Development Expert Support (OEDES) team has created a video series wherein they take you on an informative journey through the landscape of Clinical Proof of Concept. In this way, the OEDES team provides guidance and advice for Oncode Investigators and Researchers when it comes to translating our fundamental scientific insights into new diagnostics and therapeutic strategies.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>

Oncode Icons Square research strategy
News
26 November 2020
The platform that allows researchers to fully exploit available CRC studies is now available
The translation and validation of pre-clinical findings is often hampered and delayed due to unfamiliarity of basic researchers with trial cohorts providing valuable patient materials. But the new and updated CRC platform will contribute to changing that.
Bianca-OliviaNita

<span>Bianca-Olivia</span><span>Nita</span>